Ipratropium
Short-Acting Antimuscarinic (SAMA)- Drug Class
- Short-Acting Antimuscarinic (SAMA)
- Mechanism of Action (MOA)
- Blocks airway muscarinic (M3) receptors → bronchodilation; does not reduce secretions.
- Clinical Notes
- COPD exacerbations (with albuterol, as a combination nebulizer solution). Minimal systemic absorption; caution in narrow-angle glaucoma and BPH.
- Source
- FDA label
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
Used for
Same family
Got a pharmacology lecture that covers Ipratropium? Turn it into flashcards and board-style questions, free. Drop it on the home page
All pharmacology